Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
Close filters
Filter by:
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
from to

Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

Filter
11567 from 12310 pages
No results were found for the filter!
BTK-IN-6
BTK-IN-6

Item number: TGM-T62472-100mg

TargetMol
Description: BTK-IN-6 is a potent inhibitor of Bruton's tyrosine kinase (BTK) with research potential in immune diseases, cardiovascular diseases, cancer, viral infections, inflammation, metabolic/endocrine dysfunction, and neurological disorders (for more information). Target: Others
MW: 435.45 D
From 1,440.00€ *
Show details
Review
Chitin synthase inhibitor 7
Chitin synthase inhibitor 7

Item number: TGM-T62475-100mg

TargetMol
Description: Chitin synthase inhibitor 7 (compound 9c), a potent inhibitor of chitin synthase (CHS) with an IC50 of 0.37 nM, can be used to study fungal infections. Target: Others
MW: 435.47 D
From 1,440.00€ *
Show details
Review
SOS1-IN-9
SOS1-IN-9

Item number: TGM-T62478-100mg

TargetMol
Description: SOS1-IN-9 is a potent inhibitor of SOS1 that targets KRAS G12C-SOS1 with an IC50 of 116.5 nM. Target: Others
MW: 435.49 D
From 1,440.00€ *
Show details
Review
Antitumor agent-51
Antitumor agent-51

Item number: TGM-T62480-100mg

TargetMol
Description: Antitumor agent-51 is effective and selective in inhibiting the growth and migration of osteosarcoma cells, acting on MNNG/HOS cells (IC50: 21.9 nM). antitumor agent-51 is less toxic and extremely bioavailable. Target: Others
MW: 435.54 D
From 1,440.00€ *
Show details
Review
HER2-IN-12
HER2-IN-12

Item number: TGM-T62487-100mg

TargetMol
Description: HER2-IN-12 is an HER2 inhibitor with an IC50 value of 121 nM and can be used to study cancers such as breast cancer. Target: Others
MW: 436.33 D
From 1,440.00€ *
Show details
Review
P2X7 receptor antagonist-1
P2X7 receptor antagonist-1

Item number: TGM-T62488-100mg

TargetMol
Description: P2X7 receptor antagonist-1 is a purinergic P2X7 receptor antagonist with anti-neuroinflammatory effects. Target: Others
MW: 436.4 D
From 1,440.00€ *
Show details
Review
Antidepressant agent 2
Antidepressant agent 2

Item number: TGM-T62495-100mg

TargetMol
Description: Antidepressant agent 2 showed significant antidepressant effects with a MED value of 0.1 mg/kg. Target: Others
MW: 436.93 D
From 1,440.00€ *
Show details
Review
RIPK1-IN-14
RIPK1-IN-14

Item number: TGM-T62499-100mg

TargetMol
Description: RIPK1-IN-14 (Compound 41) is a potent RIPK1 inhibitor (IC50: 92 nM) with significant anti-necrotic apoptotic effects in a necrotic apoptosis model using U937 cells. Target: Others
CAS 2919964-79-5
From 1,440.00€ *
Show details
Review
WW437
WW437

Item number: TGM-T62500-100mg

TargetMol
Description: WW437, a histone deacetylase (HDAC) inhibitor, demonstrates potent anti-breast cancer activity both in vitro and in vivo. Target: Others
MW: 437.49 D
From 1,440.00€ *
Show details
Review
PD-1/PD-L1-IN-17
PD-1/PD-L1-IN-17

Item number: TGM-T62501-100mg

TargetMol
Description: PD-1/PD-L1-IN-17 (Compound P20) is a potent PD-1/PD-L1 inhibitor (IC50: 26.8 nM) and a promising lead compound for the development of inhibitors of PD-1/PD-L1 interactions, with potential applications in cancer disease research. Target: Others
MW: 437.88 D
From 1,440.00€ *
Show details
Review
Protease-Activated Receptor-1 antagonist 1
Protease-Activated Receptor-1 antagonist 1

Item number: TGM-T62507-100mg

TargetMol
Description: Protease-Activated Receptor-1 antagonist 1 (Compound 13), a PAR-1 antagonist with an IC50 of 3 nM obtained by the FLIPR technique, can be used to study thrombotic cardiovascular diseases, myocardial infarction, and peripheral arterial disease. Target: Others
MW: 438.47 D
From 1,440.00€ *
Show details
Review
Antitumor agent-74
Antitumor agent-74

Item number: TGM-T62509-100mg

TargetMol
Description: Antitumor agent-74 is a quinazoline derivative and an antitumour agent. antitumor agent-74 in combination with the regional tautomer Antitumor agent-75 (compound 14 da) (mriBIQ 13da/14da) exhibits enhanced tumour inhibition. In particular, mriBIQ 13da/14da inhibits DNA synthesis, arrests the cell cycle...
MW: 438.5 D
From 1,440.00€ *
Show details
Review
11567 from 12310 pages
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the usability of this website, serve for direct advertising or simplify interaction with other websites and social networks, will only be used with your consent. More information
Decline Accept all Configure